DFTX

#1540
Definium Therapeutics, Inc. - Common Shares
24.1 9 USD
+3.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
24.19
24.19
Rango anual
14.62
26.25
Cambio diario
+3.02%
Variación mensual
+16.19%
Variación en los últimos 6 meses
+60.09%
Cambio anual
+60.09%
Cierres anteriores
23.4 8
Open
24.1 9
Mínimo
24.1 9
High
24.1 9
Volumen
121
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 2.64 B
  • Employee 106
  • Founded 2010
  • CEO Robert Barrow
  • Website www.definiumtx.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00F13HYQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.